The tumor suppressor protein p53 coordinates the cellular response to stress through regulation of gene expression. Now, Huarte et al. (2010) identify a long intergenic noncoding RNA as a new player in p53-mediated repression of genes involved in apoptosis.
The tumor suppressor protein p53 is one of the cell's most important barriers against oncogenic transformation. By regulating the expression of thousands of genes, either directly or indirectly, p53 profoundly influences cell fate in response to stress. Several decades of research have established p53 as a transcriptional activator with high sequence specificity. However, p53 clearly also represses at least as many genes as it activates, if not more. Despite this, the mechanism of repression is less well characterized than the transactivation mechanism by p53. Now, the informative study by Huarte et al. (2010) in this issue lays the framework for a new and elegant mechanism by which p53 globally downregulates a large subset of its repression targets. These authors show that the long intergenic RNA-p21 (lincRNA-p21), a bona fide downstream target of p53, is a key inhibitor of gene expression through its interaction with heterogeneous ribonucleoprotein K (hnRNP-K).
Although the first reports of gene repression by p53 focused on suppression of the basal transcriptional machinery, subsequent studies identified more precise mechanisms occurring at specific genes (reviewed in Laptenko and Prives, 2006) . These include p53 interacting with and inhibiting specific transcription factors; displacement of specific activators from promoters due to the presence of overlapping binding sites; the recruitment by p53 of chromatin-modifying factors, such as histone deacetylases, which then block gene expression; and the binding of p53 to unique "repression" response elements. In addition, p53 may also inhibit genes indirectly by activating transcription of factors that block expression of specific genes. Most notably, many labs have demonstrated that the cell-cycle inhibitor p21 (especially within the context of Rb-family activation) is a critical mediator of p53-dependent transcriptional repression ( Figure  1 , top) (Barsotti and Prives, 2009, and references therein) . Recently, studies indicate that p53 regulates microRNAs, which either degrade mRNA targets or inhibit their translation into protein. The p53 protein facilitates not only the transcriptional activation of microRNAs but also their processing into mature, active forms (Figure 1 , middle) (Shi et al., 2010) . Now, Huarte, Rinn, and their colleagues (Huarte et al., 2010) add an exciting new route through which p53 executes widespread gene repression, specifically by activating a long intergenic RNA ( Figure  1, bottom) .
LincRNAs are large RNA molecules (primary transcript ≥5 kb) that are evolutionarily conserved across mammalian genomes. Although these RNAs are transcribed by RNA polymerase II, 5′capped, and polyadenylated like normal mRNAs, they do not code for proteins . Previous work by the Rinn group suggested that lincRNAs may repress transcription by targeting chromatin-modifying complexes to specific genomic loci (Khalil et al., 2009) .
In their new work, Huarte et al. (2010) sought to identify specific lincRNAs that operate within the p53 pathway. They constructed a tiling microarray designed to detect the expression of ?400 lincRNAs. They then incubated this array with RNA isolated from two mouse cell lines engineered with controllable expression of p53. These experiments uncovered several lincRNAs that are potential targets of p53, and the authors focused on lincRNAp21, named for its proximity to the p53-target gene p21. Importantly, they confirmed that the human ortholog of the mouse lincRNA-p21 is conserved in both sequence and regulation.
To ascertain the role of lincRNA-p21 within the p53 pathway, the authors induced the p53 response pathway and then silenced either p53 or lincRNA-p21. By comparing microarrary data under these two conditions, the authors identified a large set of genes that are derepressed in response to disruption of both p53 and lincRNA-p21. Moreover, these specific genes are highly represented in the group of genes normally repressed by p53. This is a significant finding because it implicates lincRNA-p21 as a potent downstream mediator of p53-dependent transcriptional repression that acts on a very large scale.
As mentioned, p21 itself is also thought to inhibit numerous target genes of p53. Nevertheless, disruption of lincRNA-p21 does not alter levels of p21 mRNA or protein. Furthermore, genes regulated by lincRNA-p21 do not appear to overlap with those identified in previous studies as targets of p21. These results suggest that lincRNA-p21 acts independently of p21.
In response to stress, p53 initiates a cellular program that often results in cellcycle arrest or cell death. Despite the large common set of genes regulated by p53 and lincRNA-p21, Huarte, Rinn, and coworkers found that silencing of lincRNA-p21 blocks programmed cell death (i.e., apoptosis) but not cell-cycle arrest. LincRNA-p21 represses the expression of several important prosurvival factors, which may help to explain this interesting phenotype. This hypothesis is supported by previous studies demonstrating that the repression of antiapoptotic genes by p53 is crucial for p53-facilitated cell death (Ho and Benchimol, 2003) . Further, Huarte et al. show that the activation of certain proapoptotic genes by p53, such as Noxa and Perp, depends on lincRNAp21. Therefore, lincRNA-p21 may also play an important role in determining the promoter selectivity of p53 for gene activation in addition to directing the repression of target genes.
Next, Huarte and colleagues delved into the mechanism by which lincRNAp21 represses transcription. With great satisfaction, they identify hnRNP-K as a key protein partner for lincRNA-p21. Best known for its role in chromatin remodeling and transcriptional regulation (initiation, elongation, and termination), hnRNP-K binds to a wide range of molecules, including DNA, RNA, protein kinases, and factors that remodel chromatin. Thus, hnRNP-K also participates in diverse processes, such as RNA splicing, mRNA stability, and translation (Bomsztyk et al., 2004) .
After validating the specificity of the association between lincRNA-p21 and hnRNP-K and identifying the region of the RNA necessary for their binding, the authors again turned to microarray analyses to assess the importance of this interaction. Indeed, a large percentage of genes commonly inhibited by p53 and lincRNA-p21 also require hnRNP-K for their repression. Further, hnRNP-K is recruited to promoters for genes that are downregulated by the p53/lincRNA-p21/hnRNP-K axis, and this recruitment depends on lincRNA-p21. Taken together, these results imply that hnRNP-K plays a significant and direct role in executing gene repression mediated by p53 and lincRNA-p21.
Supporting this model, previous studies found that hnRNP-K is present in a repressive complex with the linker histone H1.2. Moreover, this complex blocks chromatin acetylation and subsequent transcriptional activation by p53 and the transcription factor complex p300 (Kim et al., 2008) . In contrast, however, Moumen et al. (2005) found that hnRNP-K cooperates with p53 as a coactivator of transcription in response to DNA damage. In the system used by Huarte and colleagues, hnRNP-K and lincRNA-p21 have independent roles as well, with hnRNP-K sharing an overlapping set of target genes with p53 that are not regulated by lincRNA-p21. Thus, it is not clear that lincRNA-p21 and hnRNP-K are more closely related than p53 and hnRNP-K. Nevertheless, the large amount of data generated by the new microarray analyses supports a more widespread role for hnRNP-K in p53-dependent gene repression than in p53-dependent gene activation.
The Huarte et al. findings raise several key questions. Does the binding partner of hnRNP-K determine whether it acts as a positive or negative regulator of transcription? For example, does the interaction between p53 and hnRNP-K serve as a platform for other coactivators, whereas the association between lincRNA-p21 and hnRNP-K favors formation of a repressive complex? This model would indeed explain the seemingly contradictory roles of hnRNP-K with regard to p53 activity. Further, how does lincRNA-p21 influence the binding (Middle) The microRNA miR-34a degrades or inhibits translation of the mRNAs of genes important for both cell-cycle progression and survival. (Bottom) A new class of p53 targets, exemplified by the long intergenic noncoding RNA lincRNA-p21, is activated by p53 and then inhibits gene expression (Huarte et al., 2010) . Although the exact mechanism of gene repression is unclear, lincRNA-p21 interacts with heterogeneous ribonucleoprotein K (hnRNP-K) to downregulate a large group of genes that are repressed by p53, including several that are important for cell survival.
of hnRNP-K to specific genomic loci? Is there functional significance to the remarkable proximity (?15 kb) of lincRNA-p21 to the p21 gene? If these loci are regulated interdependently, they may act as a key molecular switch between life and death. Finally, given the importance of lincRNA-p21 to p53-dependent cell death, is lincRNA-p21 mutated in cancer? Answers to each of these questions will certainly enrich our understanding of the functional relationship between p53 and this powerful class of regulatory molecules, lincRNAs.
Stem cells have the immense responsibility of maintaining tissue and organism homeostasis over the lifetime of an individual. As such, stem cells are speculated to have evolutionary characteristics that offer protection against acute insults, allowing them to survive and to repopulate their tissues in the short term. However, they must also act as self-renewing guardians of the genome to ensure maximal integrity of the genomic code for future stem cells and their mature tissue progeny. The hematopoietic (blood) system is perhaps the best studied tissue in terms of its hierarchical development from a small number of long-term stem cells that are relatively quiescent, to progenitors that proliferate and differentiate, and then to mature blood cell lineages that are produced by the billion each day. Hematopoietic stem cells are thought to be resistant to injury including DNA damage, which may be related to their specific gene expression programs, epigenetic factors, or exogenous protection by the stem cell "niche." Two new reports in Cell Stem Cell from the laboratories of Emmanuelle Passegué (Mohrin et al., 2010) and John Dick (Milyavsky et al., 2010) further our understanding of how hematopoietic stem cells respond to radiation-induced DNA damage.
So how do quiescent stem cells handle genotoxic insults? Mohrin et al. (2010) found that murine hematopoietic stem and progenitor cells (HSPCs)-defined as bone marrow cells expressing the markers: lineage − /c-Kit + /Sca-1 + /Flk2 − -were more resistant to apoptosis induced by a specific dose of ionizing radiation than were more differentiated progenitor cells (Figure 1) . The unique DNA damage response of mouse HSPCs involves the tumor suppressor protein p53 and is lost when stem cells are forced out of quiescence and into the cell cycle by treatment with chemotherapy or cytokines. Not only are quiescent HSPCs poised to resist apoptosis as evidenced by their antiapoptotic gene expression program, but they are also able to repair their DNA by nonhomologous end joining (NHEJ). Repair of DNA damage through homologous recombination (which has a lower error rate than NHEJ) requires that cells enter the cell cycle; thus, quiescent stem cells must rely on NHEJ as an alternative. The reliance of quiescent adult tissue stem cells on NHEJ for the repair of DNA damage may in fact be a general stem cells and DnA Damage: Persist or Perish?
